Skip to main content
Atrás
Watch Compare

CHAMPIONS ONCOLOGY, INC.

Calidad de datos: 100%
CSBR
Nasdaq Manufacturing Chemicals
$5.85
▼ $0.18 (-2.99%)
Cap. Mercado: 81.24 M
Precio
$5.85
Cap. Mercado
81.24 M
Rango del Día
$5.70 — $5.86
Rango de 52 Semanas
$5.50 — $9.63
Volumen
9,002
Apertura $5.86
Promedio 50D / 200D
$6.18
5.38% below
Promedio 50D / 200D
$6.73
13.03% below

Quick Summary

Puntos Clave

Revenue grew 8.53% annually over 5 years — modest growth
Generating 3.82 M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.01%
Capital efficient — spends only 1.00% of revenue on capex

Crecimiento

Revenue Growth (5Y)
8.53%
Above sector avg (1.82%)
Revenue (1Y)13.54%
Earnings (1Y)N/A
FCF Growth (3Y)152.21%

Calidad

Return on Equity
-55.44%
Below sector avg (-53.41%)
ROIC-26.26%
Net Margin-4.04%
Op. Margin-4.53%

Seguridad

Debt / Equity
N/A
Current Ratio0.98
Interest CoverageN/A

Valoración

PE (TTM)
-34.67
Below sector avg (-1.48)
P/B Ratio18.97
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -34.7 -1.5
P/B 19.0 1.6
ROE % -55.4 -53.4
Net Margin % -4.0 -41.5
Rev Growth 5Y % 8.5 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 13.54% Revenue Growth (3Y) 2.81%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 8.53% Earnings Growth (5Y) 89.83%
Profitability
Revenue (TTM) 57.95 M Net Income (TTM) -2.34 M
ROE -55.44% ROA -8.00%
Gross Margin N/A Operating Margin -4.53%
Net Margin -4.04% Free Cash Flow (TTM) 3.82 M
ROIC -26.26% FCF Growth (3Y) 152.21%
Safety
Debt / Equity N/A Current Ratio 0.98
Interest Coverage N/A Asset Turnover 1.98
Working Capital -492,000 Tangible Book Value 3.95 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -34.67 Forward P/E N/A
P/B Ratio 18.97 P/S Ratio 1.40
PEG Ratio -0.39 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4.70%
Market Cap 81.24 M Enterprise Value 74.11 M
Per Share
EPS (Diluted TTM) -0.17 Revenue / Share 4.17
FCF / Share 0.27 OCF / Share 0.32
EPS CAGR (1Y) N/A EPS CAGR (5Y) 101.54%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1.00% FCF Conversion -162.87%
SBC-Adj. FCF 2.68 M Growth Momentum 5.01

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 56.94 M 50.16 M 53.87 M 49.11 M 41.04 M
Net Income 4.70 M -7.28 M -5.34 M 548,000.0 362,000.0
EPS (Diluted) 0.33 -0.54 -0.39 0.04 0.02
Gross Profit — — — — —
Operating Income 4.55 M -7.36 M -5.26 M 607,000.0 366,000.0
EBITDA — — — — —
R&D Expenses 6.83 M 9.54 M 11.55 M 9.37 M 7.20 M
SG&A Expenses — — — — —
D&A 1.60 M 1.70 M 2.10 M 1.50 M 1.20 M
Interest Expense — — — — —
Income Tax -75,000.0 -32,000.0 68,000.0 35,000.0 75,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 32.34 M 26.13 M 34.31 M 35.38 M 27.59 M
Total Liabilities 28.57 M 28.04 M 29.68 M 26.28 M 20.16 M
Shareholders' Equity 3.77 M -1.90 M 4.64 M 9.10 M 7.43 M
Total Debt — — — — —
Cash & Equivalents — — — — —
Current Assets 22.37 M 13.64 M 19.46 M 19.66 M 12.63 M
Current Liabilities 23.85 M 21.54 M 21.73 M 17.48 M 11.20 M